BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 16775119)

  • 1. Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance.
    Fong D; Steurer M; Obrist P; Barbieri V; Margreiter R; Amberger A; Laimer K; Gastl G; Tzankov A; Spizzo G
    J Clin Pathol; 2008 Jan; 61(1):31-5. PubMed ID: 16775119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer.
    Spizzo G; Went P; Dirnhofer S; Obrist P; Moch H; Baeuerle PA; Mueller-Holzner E; Marth C; Gastl G; Zeimet AG
    Gynecol Oncol; 2006 Nov; 103(2):483-8. PubMed ID: 16678891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival.
    Varga M; Obrist P; Schneeberger S; Mühlmann G; Felgel-Farnholz C; Fong D; Zitt M; Brunhuber T; Schäfer G; Gastl G; Spizzo G
    Clin Cancer Res; 2004 May; 10(9):3131-6. PubMed ID: 15131054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater.
    Piscuoglio S; Lehmann FS; Zlobec I; Tornillo L; Dietmaier W; Hartmann A; Wünsch PH; Sessa F; Rümmele P; Baumhoer D; Terracciano LM
    J Clin Pathol; 2012 Feb; 65(2):140-5. PubMed ID: 22130902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ep-CAM is a significant prognostic factor in pancreatic cancer patients by suppressing cell activity.
    Akita H; Nagano H; Takeda Y; Eguchi H; Wada H; Kobayashi S; Marubashi S; Tanemura M; Takahashi H; Ohigashi H; Tomita Y; Ishikawa O; Mori M; Doki Y
    Oncogene; 2011 Aug; 30(31):3468-76. PubMed ID: 21399662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer.
    Schmidt M; Hasenclever D; Schaeffer M; Boehm D; Cotarelo C; Steiner E; Lebrecht A; Siggelkow W; Weikel W; Schiffer-Petry I; Gebhard S; Pilch H; Gehrmann M; Lehr HA; Koelbl H; Hengstler JG; Schuler M
    Clin Cancer Res; 2008 Sep; 14(18):5849-55. PubMed ID: 18794096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Ep-CAM in intestinal metaplasia, gastric epithelial dysplasia and gastric adenocarcinoma.
    Joo M; Kim H; Kim MK; Yu HJ; Kim JP
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1039-45. PubMed ID: 15955212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer.
    Spizzo G; Went P; Dirnhofer S; Obrist P; Simon R; Spichtin H; Maurer R; Metzger U; von Castelberg B; Bart R; Stopatschinskaya S; Köchli OR; Haas P; Mross F; Zuber M; Dietrich H; Bischoff S; Mirlacher M; Sauter G; Gastl G
    Breast Cancer Res Treat; 2004 Aug; 86(3):207-13. PubMed ID: 15567937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of Ep-CAM AND Her-2/neu overexpression in invasive breast cancer.
    Spizzo G; Obrist P; Ensinger C; Theurl I; Dünser M; Ramoni A; Gunsilius E; Eibl G; Mikuz G; Gastl G
    Int J Cancer; 2002 Apr; 98(6):883-8. PubMed ID: 11948467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic Trop-1/Ep-CAM overexpression is associated with a favorable outcome in node-positive breast cancer.
    Alberti S; Ambrogi F; Boracchi P; Fornili M; Querzoli P; Pedriali M; La Sorda R; Lattanzio R; Tripaldi R; Piantelli M; Biganzoli E; Coradini D
    Jpn J Clin Oncol; 2012 Dec; 42(12):1128-37. PubMed ID: 23072840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of Ep-CAM (17-1A) in squamous cell cancers of the lung.
    Piyathilake CJ; Frost AR; Weiss H; Manne U; Heimburger DC; Grizzle WE
    Hum Pathol; 2000 Apr; 31(4):482-7. PubMed ID: 10821496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ep-CAM expression in squamous cell carcinoma of the esophagus: a potential therapeutic target and prognostic marker.
    Stoecklein NH; Siegmund A; Scheunemann P; Luebke AM; Erbersdobler A; Verde PE; Eisenberger CF; Peiper M; Rehders A; Esch JS; Knoefel WT; Hosch SB
    BMC Cancer; 2006 Jun; 6():165. PubMed ID: 16796747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical Classification of Ampullary Carcinomas: Critical Reappraisal Fails to Confirm Prognostic Relevance for Recently Proposed Panels, and Highlights MUC5AC as a Strong Prognosticator.
    Xue Y; Reid MD; Balci S; Quigley B; Muraki T; Memis B; Xia J; Hacihasanoglu E; Bedolla G; Pehlivanoglu B; Kim GE; Tajiri T; Ohike N; Aneja R; Krasinskas AM; Adsay V
    Am J Surg Pathol; 2017 Jul; 41(7):865-876. PubMed ID: 28505002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor cell expression of immune inhibitory molecules and tumor-infiltrating lymphocyte count predict cancer-specific survival in pancreatic and ampullary cancer.
    Sideras K; Biermann K; Yap K; Mancham S; Boor PPC; Hansen BE; Stoop HJA; Peppelenbosch MP; van Eijck CH; Sleijfer S; Kwekkeboom J; Bruno MJ
    Int J Cancer; 2017 Aug; 141(3):572-582. PubMed ID: 28470686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma.
    Schultz NA; Werner J; Willenbrock H; Roslind A; Giese N; Horn T; Wøjdemann M; Johansen JS
    Mod Pathol; 2012 Dec; 25(12):1609-22. PubMed ID: 22878649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
    Ridwelski K; Meyer F; Schmidt U; Lippert H
    Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancer.
    Songun I; Litvinov SV; van de Velde CJ; Pals ST; Hermans J; van Krieken JH
    Br J Cancer; 2005 May; 92(9):1767-72. PubMed ID: 15870832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expressions of Ep-CAM and cyclin D1 and their clinical significance in gallbladder carcinoma].
    Ren G; Yu G; Liu LW; Ma L
    Zhonghua Zhong Liu Za Zhi; 2009 Nov; 31(11):841-4. PubMed ID: 20137349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of immunohistochemical expression of CK7 and CK20 in curatively resected ampulla of Vater cancer.
    Yun SP; Seo HI
    BMC Gastroenterol; 2015 Nov; 15():165. PubMed ID: 26603157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Ep-CAM, but not of E48, associates with nodal involvement in advanced squamous cell carcinomas of the larynx.
    Romeu C; Farré X; Cardesa A; Nadal A
    Histopathology; 2013 May; 62(6):954-61. PubMed ID: 23672314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.